Published in Proc Natl Acad Sci U S A on October 25, 2016
F901318 Single Ascending Dose Study in Healthy Male Volunteers | NCT02142153
F901318 Multiple Ascending Dose Study | NCT02342574
Single Ascending Oral Dose Study of F901318 | NCT02394483
Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects (ORALMAD) | NCT02737371
The antifungal pipeline: a reality check. Nat Rev Drug Discov (2017) 0.77
Identification and Evaluation of Novel Drug Targets against the Human Fungal Pathogen Aspergillus fumigatus with Elaboration on the Possible Role of RNA-Binding Protein. Iran Biomed J (2016) 0.75
Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist (2017) 0.75
Bridging the Gap to Non-toxic Fungal Control: Lupinus-Derived Blad-Containing Oligomer as a Novel Candidate to Combat Human Pathogenic Fungi. Front Microbiol (2017) 0.75
Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res (2008) 19.09
Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov (2006) 15.21
Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10
How were new medicines discovered? Nat Rev Drug Discov (2011) 7.00
Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot Cell (2005) 4.36
Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell (2004) 2.63
Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure (2000) 1.98
Therapy for fungal diseases: opportunities and priorities. Trends Microbiol (2010) 1.95
Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA. J Antimicrob Chemother (2001) 1.82
Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog (2013) 1.70
Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol (2012) 1.61
Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ (2011) 1.61
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. Infect Immun (1996) 1.60
Development of Saccharomyces cerevisiae as a model pathogen. A system for the genetic identification of gene products required for survival in the mammalian host environment. Genetics (2001) 1.46
Infectious Disease. How to bolster the antifungal pipeline. Science (2015) 1.45
Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clin Infect Dis (2015) 1.40
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect (2009) 1.32
Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med (2014) 1.31
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci Transl Med (2015) 1.29
Teriflunomide and its mechanism of action in multiple sclerosis. Drugs (2014) 1.08
On dihydroorotate dehydrogenases and their inhibitors and uses. J Med Chem (2013) 1.01
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus. Antimicrob Agents Chemother (2004) 1.01
Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase. Eur J Biochem (2000) 1.01
Recombinant human dihydroorotate dehydrogenase: expression, purification, and characterization of a catalytically functional truncated enzyme. Arch Biochem Biophys (1995) 1.00
The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun (1999) 0.98
Overview of treatment options for invasive fungal infections. Med Mycol (2011) 0.94
Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect Dis Clin North Am (2015) 0.88
Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors. Mini Rev Med Chem (2011) 0.86
Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans. FEBS J (2006) 0.85
Serum 'uracil plus uridine' levels in normal subjects and their possible significance. J Clin Pathol (1974) 0.82
The role of the de novo pyrimidine biosynthetic pathway in Cryptococcus neoformans high temperature growth and virulence. Fungal Genet Biol (2014) 0.81